Nutrition
Volume 26, Issue 1 , Pages 10-32 , January 2010

Relationship between serum protein and mortality in adults on long-term hemodialysis: Exhaustive review and meta-analysis

  • Marietjie Herselman, Ph.D.

      Affiliations

    • Division of Human Nutrition, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, South Africa
    • Corresponding Author InformationCorresponding author. Tel.: +27-21-938-9259; fax: +27-21-933-2991.
    • ,
  • Nazeema Esau, B.Sc. Dietetics

      Affiliations

    • Division of Human Nutrition, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, South Africa
    • ,
  • Jeanne-Marie Kruger, M.Nutr.

      Affiliations

    • Division of Human Nutrition, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, South Africa
    • ,
  • Demetre Labadarios, M.B., Ch.B., Ph.D.

      Affiliations

    • Knowledge Systems, Human Sciences Research Council and Tygerberg Academic Hospital, Tygerberg, South Africa
    • ,
  • M. Rafique Moosa, M.D.

      Affiliations

    • Department of Medicine, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, South Africa

Received 25 February 2009 ,Accepted 30 July 2009.

References 

  1. Acchiardo SR, Moore LW, Latour PA. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int. 1983;16(Suppl):S199–S203
  2. Acchiardo SR, Moore LW, Burk L. Morbidity and mortality in hemodialysis patients. ASAIO Trans. 1990;36:M148–M151
  3. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly used measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482
  4. Lowrie EG, Lew NL, Huang WH. Race and diabetes as death risk predictors in hemodialysis patients. Kidney Int. 1992;42(Suppl 38):22–32
  5. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–1006
  6. Fleishman E, Teal N, Dudley J, Bower JD, Salahudeen AK. Underweight rather than overweight predicts death in hemodialysis population. Wien Klin Wochenschr. 1998;110(suppl 4):14–15
  7. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31:997–1006
  8. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55:1560–1567
  9. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136–1148
  10. Goldstein DJ. Assessment of nutritional status in renal diseases. In:  Mitch WE,  Klahr S editor. Handbook of nutrition and the kidney. 3rd ed. New York: Lippincott-Raven; 1998;p. 45–86
  11. Schrander vd Meer AM, Van Saase JL, Roodvoets AP, Van Dorp WT. Mortality in patients receiving renal replacement therapy, a single center study. Clin Nephrol. 1995;43:174–179
  12. Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int. 1992;42(Suppl 38):4–15
  13. Methe H, Weis M. Atherogenesis and inflammation—was Virchow right?. Nephrol Dial Transplant. 2007;22:1823–1827
  14. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554
  15. Gibson RS. Principles of nutritional assessment. 2nd ed.. New York: Oxford University Press; 2005;
  16. Gøtzsche PC, Harden A. Searching for non-randomised studies. NRSMG, 7th draft; 2000. Available at: http://www.cochrane.dk/nrsmg/docs/chap3.rtf. Accessed October 12, 2005.
  17. Cochrane Renal Group. Renal group data extraction form. Available at: http://www.cochrane-renal.org/docs/data_extraction_form.doc 2005. Accessed November 27, 2008.
  18. Khan KS, Ter Riet G, Glanville J, Sowden AJ, Kleijnen J. Undertaking systematic reviews of research on effectiveness. CRD's guidance for those carrying out or commissioning reviews. CRD report no. 4. 2nd ed.. York, UK: University of York, York Publishing Services; 2001;
  19. STROBE statement of essential items version 3; September 2005. Available at: http://www.strobe-statement.org/PDF%20hochladen/STROBE-Checklist-Version3.pdf. Accessed November 8, 2005.
  20. Anderson P, Green S. Cochrane collaboration open learning material for reviewers, version 1.1; November 2002. Available at: www.cochrane-net.org/openlearning/HTML/modA1-5.htm. Accessed November 2, 2005.
  21. Wells G, Shea B, O'Connell D, Robertson J, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Available at: http://www.iri.ca/programs/ccu/oxford.htm. Accessed October 13, 2005.
  22. NCSS statistical and power analysis software package (version 2007). Available at: www.ncss.com. Accessed December 1, 2008.
  23. Hamer M, Chida Y. Walking and primary prevention: a meta-analysis of prospective cohort studies. Br J Sports Med. 2008;42:238–243
  24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  25. Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based medicine. London: Royal Society of Medicine Press; 2003;
  26. In:  Higgins JPT,  Green S editor. Cochrane handbook for systematic reviews of interventions. West Sussex, UK: John Wiley & Sons; 2008;
  27. Pai M. Systematic reviews of non-experimental (observational) studies. The Cochrane Collaborative Review group on HIV Infection and AIDS. Available at: www.medepi.org/meta. Accessed November 2005.
  28. Galandi D, Schwarzer G, Antes G. The demise of the randomised controlled trial: bibliometric study of the German-language health care literature, 1948 to 2004. BMC Med Res Methodol. 2006;6:30
  29. Dickerson K. Systematic reviews in epidemiology: why are we so far behind?. Int J Epidemiol. 2002;31:6–12
  30. Kayzen GA, Dubin JA, Muller H-G, Mitch WE, Rodales LM, Levin NW. HEMO Study Group. Relationships among inflammation, nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002;61:2240–2249
  31. Tripepi G, Mallamaci F, Zocalli C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best marker by multivariate modeling. J Am Soc Nephrol. 2005;16:S83–S88
  32. Wetmore JB, Lovett DH, Hung AM, Cook-Wiens G, Mahnken JD, Sen S, et al. Associations of interleukin-6, C-reactive protein and amyloid A with mortality in haemodialysis patients. Nephrology. 2008;13:593–600
  33. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001;12:1549–1557
  34. Carrero JS, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S, et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr. 2007;85:695–701
  35. Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant. 2000;15:1624–1630
  36. Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis patients: relationships among them and to death risk. Semin Nephrol. 1992;12:276–283
  37. Fernandez-Reyes MJ, Alvarez-ude F, Sanchez R, Mon C, Iglesias P, Vazquez A. Nutritional status, comorbidity and inflammation in hemodialysis. Nefrologia. 2000;20:540–549
  38. Bilbrey GL. Identification and treatment of protein calorie malnutrition in chronic hemodialysis patients. Dial Transplant. 1989;16:669–677
  39. Heini AF, Forehand J, Kirk KA, Morgan SL. Albumin levels and body weight in hemodialysis (HD) patients. Wien Klin Wochenschr. 1998;110(Suppl 4):10
  40. Herselman MG, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein–energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. J Ren Nutr. 2000;10:7–15
  41. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–421
  42. Kaysen GA, Rathore V, Sheaker GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995;48:510–516
  43. Gil H-W, Yang J-O, Lee E-Y, Lee E-M, Choi JS, Hong S-Y. The effect of dialysis membrane flux on amino acid loss in hemodialysis patients. J Korean Med Sci. 2007;22:598–603
  44. Keusch GT. Nutrition and infection. In:  Shils ME,  Olson JA,  Shike M editor. Modern nutrition in health and disease. 8th ed. London: Lea & Febiger; 1994;p. 1241–1258
  45. Bistrian BR, McCowen KC, Chan S. Protein–energy malnutrition in dialysis patients. Am J Kidney Dis. 1999;33:172–175
  46. Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006;290:F262–F272
  47. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001;19:53–61
  48. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915–924
  49. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319–326
  50. Hill GL. Body composition research: implications for the practice of clinical nutrition. JPEN. 1992;16:197–219
  51. Sjöström M, Wretlind ML, Karlberg I, Eden E, Lundhölm K. Ultrastructural changes and enzyme activities for energy production in hearts concomitant with tumor-associated malnutrition. J Surg Res. 1987;42:304–313
  52. Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital Heart J. 2003;4:232–235
  53. Piza J, Troper L, Cespedes R, Miller JH, Berenson GS. Myocardial lesions and heart failure in infantile malnutrition. Am J Trop Med Hyg. 1971;20:343–355
  54. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in heart failure. Lancet. 1997;349:1050–1053
  55. Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, et al. Clinical value of the malnutrition–inflammation–atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract. 2008;108:C99–105
  56. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883–889
  57. Freeman LM, Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev. 1994;52:340–347
  58. Bistrian B, Schwartz J, Istifan NW. Cytokines, muscle proteolysis and the catabolic response to infection and inflammation. Proc Soc exp Biol Med. 1992;200:220–223
  59. Ravasco P, Monteiro-Grillo I, Camilo M. How relevant are cytokines in colorectal cancer wasting?. Cancer J. 2007;13:392–398
  60. Yokoyama T, Vava L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 1993;92:2302–2312
  61. Cianflone K, Vu H, Zhang Z, Sniderman AD. Effect of albumin on lipid synthesis, apoB100 secretion, and LDL catabolism in human HepG2 cells. Atherosclerosis. 1994;107:125–135
  62. Kario K, Matsuo T, Kobayashi H. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III. Thromb Res. 1992;66:489–498
  63. Ekseth K, Abildgaard L, Vegfors M, Berg-Johnsen J, Engdahl O. The in vitro effects of crystalloids and colloids on coagulation. Anaesthesia. 2002;57:1102–1108
  64. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7:728–736
  65. Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int. 1997;52:761–770
  66. Gris JC, Branger B, Vécina F, Sabadani BA, Fourcade J, Schved JF. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int. 1994;46:807–813
  67. Vanholder R, Van Laecke S, Verbeke F, Glorieux G, Van Biesen W. Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies. NDT Plus. 2008;1:2–10
  68. Misra M, Ashworth J, Reaveley DA, Muller B, Brown EA. Nutritional effects of amino acid dialysate (Nutrineal) in CAPD patients. Adv Perit Dial. 1996;12:311–314
  69. Mortelmans AK, Duym P, Vandenbroucke J, De-Smet R, Dhont A, Lesaffer G, et al. Intradialytic parenteral nutrition in malnourished hemodialysis patients: a prospective long-term study. JPEN. 1999;23:90–95
  70. Eustace JA, Coresh J, Kutchey C, Te PL, Gimenez LF, Scheel PJ, et al. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminaemia. Kidney Int. 2000;57:2527–2538
  71. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA. Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis. 1994;23:808–816
  72. Donini LM, Savina C, Ricciardi LM, Coletti C, Paolini M, Scavone L, et al. Predicting the outcome of artificial nutrition by clinical and functional indices. Nutrition. 2009;25:11–19

PII: S0899-9007(09)00304-9

doi: 10.1016/j.nut.2009.07.009

Nutrition
Volume 26, Issue 1 , Pages 10-32 , January 2010

Article Tools

* Image Usage & Resolution